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Abstract : Spindle cell carcinoma (SpCC) of the breast is quite a rare modality classified to the metaplastic car-
cinoma of the breast. Regarding its biological behavior and the prognosis of the patients with this rare tumor, 
it has been remaining controversial. We herein report an 88 year-old woman who had a huge bleeding tumor 
on the right breast. She was a high-aged woman with low activities of daily life, even with some suspicion of 
distant organ metastasis. While the tumor proved to drastically bleed due to the tumor disintegration, a right 
simple mastectomy was performed. According to the histopathologic examinations, sarcomatoid spindle cells 
with severe atypia were observed. By an immunohistochemical examination, the tumor had proved to express 
neither estrogen receptor, progesterone receptor nor HER2 receptor. Moreover an immunohistochemical ex-
pression of AE1/3 and CAM5.2, defining an epithelial neoplasm were observed in addition to an expression of 
vimentin. From these findings, this bleeding tumor was diagnosed as spindle cell carcinoma of the breast. J. 
Med. Invest. 67 : 365-367, August, 2020
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INTRODUCTION
 
Spindle cell carcinoma (SpCC) of the breast is quite a rare 
tumor (1, 2) classified to the metaplastic carcinoma in general 
rules for clinical and pathological recording of breast cancer 
established by the Japanese Breast Cancer Society (3), and a 
mixture of sarcomatous spindle cells and epithelial tumor cells 
can account for the histopathologic characteristics of this tumor. 
Although the tumor often lacks the expression of ER, PgR, and 
HER2, it remains controversial whether its biological behavior is 
aggressive and the prognosis of the patients with this rare tumor 
is unfavorable (4-9). 
Moreover while a study population for this tumor has been 
small, clinical features including the effectiveness derived from 
chemotherapy and radiotherapy has not been well appreciated.
We herein report an 88 year-old woman with SpCC of the 
breast who had undergone a surgical resection. 
CASE REPORT
An 88-year old woman, who had a large tumor on the right 
breast came to see our institute. 
The round-shaped tumor with a comparatively regular sur-
face measuring 5.0cm in size was palpable in the lateral upper 
quarter area of the right breast. Moreover the tumor was found 
to partially invaded to the surface of the skin and a slight 
hemorrhage due to the disintegration of the tumor was also 
demonstrated. 
In the laboratory examinations, the value of hemoglobin was 
found to be low (9.7g/dL), which was probably brought about by 
the hemorrhage of the breast tumor. There was no increase in 
the serum value of such tumor markers as CEA, CA15-3.
While she could not stand and stay still, a mammography 
and magnetic resonance imaging examination (MRI) could not 
be appreciated. Computed tomography demonstrated a breast 
tumor measuring 5 cm in size (Fig. 1). There existed no finding 
for distant metastasis and nodal metastasis in the axillary 
lymph nodes.
Preoperative histological examination demonstrated the 
histological diagnosis as ductal carcinoma, but the definitive 
histological type could not be determined.
While she was a high-aged woman with low activities of daily 
life, and the tumor proved to continuously bleed due to the tumor 
disintegration, a right mastectomy was performed (Fig. 2).  
By the Histological examination, sarcomatoid spindle cells 
with severe atypia were observed (Fig. 3).  An immunohistologi-
cal examinations demonstrated that tumor was found to express 
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Fig 1.　Photo of computed tomography. A breast tumor measuring 
5 cm in size with a comparably regular surface was demonstrated.
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neither ER, PgR nor HER2 receptor. An immunoreactivity for 
Ki-67 proved to be 32% (Fig. 4). An expression of AE1/3 and 
CAM5.2, defining an evidence for epithelial neoplasm were 
observed (Fig. 5). Moreover a strong expression of vimentin was 
also observed (Fig. 6). These findings could compensate for the 
pathologic features of spindle cell carcinoma of the breast.
DISCUSSION
SpCC of the breast, a subtype classified as the carcinoma with 
metaplasia, spindle cell type in WHO classification, is quite a 
rare tumor, accounting for less than 0.5% among carcinoma of 
the breast (1, 2). 
The most common and outstanding clinical features of this 
tumor is a formation of large palpable mass (10). High density 
tumor shadow with a unclear boarder on mammography, and 
tumor shadow with irregular shape, microlobulated margin, 
complex echogenicity, parallel orientation, and posterior acoustic 
enhancement on ultrasonography and higher intensity of the 
signal on T2 MRI imaging can account for the common features 
of breast SpCC in diagnostic images (11), but in our case mam-
mography and MRI test could not be accomplished because of the 
physical condition. 
While SpCC of the breast has been known to lack in expression 
of ER, PgR, and HER2 in many cases (8, 11), the malignant po-
tential of this tumor has been reported to be more aggressive (6, 
7). However, on the other hand, less frequent incidence of lymph 
node metastasis and more favorable prognosis of patients with 
SpCC of the breast, in spite of the large growth of the tumor, as 
is concomitant with our case, has been also reported (4, 5, 7). 
Even when, she had distant metastasis that would prevent 
curative resection, surgical treatment might be required, even 
palliative resection. Because the hemorrhage owing to the dis-
intergration of the tumor would definitively spoil the QOL of the 
patient. Indeed, the general condition of the patient remarkably 
improved after surgical resection.
Although chemotherapy other than hormonal therapy might 
be considered, no definitive anticancer drugs exerting a high 
efficacy for SpCC of the breast has been presented due to the 
small number of this modality. As our case is high-aged woman 
and activities of daily living (ADL) proved to be low, she desired 
to avoid chemotherapy.
Fig 2.　Macroscopic finding.
Cut surface demonstrated the solid well-circumscribed tumor with 
central bleeding due to necrosis of the tumor.
Fig 3.　Histopathologic finding.
Sarcomatoid spindle cells with atypia were shown. 
A. Magnification ×10. B. Magnification ×20. C. magnification ×40.
Fig 4.　Photo of immunohistochemical expression for Ki-67.
An immunoreactivity was 32%.
A. Magnification ×20. B. magnification ×40.
Fig 5.　Photo of immunohistochemical expression for keratin.
Strong expression of AE1/3 (A. Magnification ×20.) and CAM5.2 
(B. Magnification ×20.) in the cell membrane of the tumor cells was 
demonstrated, showing this tumor could be an epithelial neoplasm.
Fig 6.　Photo of immunohistochemical expression for vimentin.
Strong expression of vimentin was demonstrated.
A. Magnification ×20. B. magnification ×40.
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There exists no clear understanding for the pathogenetic 
mechanism for the occurrence of SpCC of the breast. It remains 
still controversial whether this tumor originated from epithelial 
growth or derived from mesenchymal origin. Possible correlation 
of the concept of epithelial-mesenchymal transition (EMT) with 
the pathogenesis of SpCC of the breast has been demonstrated 
(12).
Pathologic investigation in this case demonstrated both a 
sarcomatoid features containing spindle shaped-cells with abun-
dant mitoses and an epithelial proliferation. 
Tumor cells in breast SpCC carcinoma has been derived from 
myoepithelial cells or differentiate to myoepithelial cells (13). In 
our case, immunohistochemical examination demonstrated an 
expression of both cytokeratin A1/A3 and vimentin, showing the 
correlation of myoepithelial cells with the pathogenesis of SpCC 
of the breast.
While the tumor of our case contained neither hormone recep-
tors nor HER2 receptor, it was found to have strong expression 
of Ki-67, substantiating the malignant potential of the tumor. It 
has been reported that tumor cells in SpCC contained strong ex-
pression of Ki-67 expression, demonstrating an acquisition of the 
more aggressive cellular potential while epithelial components 
transit to the sarcomatoid lesion diagnosed as SpCC (14).
Nevertheless, meticulous follow-up for tumor recurrence 
should be mandatory.
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